AHT Stock Overview
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Ashland Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$89.50 |
| 52 Week High | US$91.50 |
| 52 Week Low | US$65.50 |
| Beta | 0.92 |
| 1 Month Change | 2.87% |
| 3 Month Change | 26.06% |
| 1 Year Change | -2.19% |
| 3 Year Change | 16.23% |
| 5 Year Change | 26.68% |
| Change since IPO | 175.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| AHT | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 2.3% | 0.5% | 1.8% |
| 1Y | -2.2% | 0.2% | 2.2% |
Return vs Industry: AHT underperformed the German Chemicals industry which returned 0.2% over the past year.
Return vs Market: AHT underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| AHT volatility | |
|---|---|
| AHT Average Weekly Movement | 4.0% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AHT has not had significant price volatility in the past 3 months.
Volatility Over Time: AHT's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1924 | 3,800 | Guillermo Novo | www.ashland.com |
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
Ashland Inc. Fundamentals Summary
| AHT fundamental statistics | |
|---|---|
| Market cap | €4.50b |
| Earnings (TTM) | €143.90m |
| Revenue (TTM) | €2.00b |
31.2x
P/E Ratio2.2x
P/S RatioIs AHT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AHT income statement (TTM) | |
|---|---|
| Revenue | US$2.14b |
| Cost of Revenue | US$1.54b |
| Gross Profit | US$601.00m |
| Other Expenses | US$447.00m |
| Earnings | US$154.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 3.07 |
| Gross Margin | 28.10% |
| Net Profit Margin | 7.20% |
| Debt/Equity Ratio | 43.9% |
How did AHT perform over the long term?
See historical performance and comparison